drugset / Trial / NCT00791076

The Effect of Pancreatic Polypeptide on Insulin Requirements for Type 1 & Post-pancreatectomy Diabetic Patients

NCT00791076

Phase 2 Terminated 8 enrolled Johns Hopkins University
RandomizedParallel-groupSingle-blindTreatment

Summary

The goal of this research is to see if pancreatic polypeptide (PP), a hormone that is naturally produced by the pancreas and that works to control the amount of glucose that the liver makes, will reduce the amount of insulin required for people who must take insulin to maintain their normal blood glucose level.

Timeline

Start
2007-10
Primary completion
2010-06
Completion
2010-06

Drugs

EvaluationDrugModalityDoseRoute
Comparator Pancreatic Polypeptide Peptide 2 unknown